Eigen Therapeutics

Eigen Therapeutics is a seed-stage biotechnology company with the mission to make cancer easier to detect and eliminate. Founded by two key contributors to pioneering predictive medicine platforms from renowned laboratories, the company focuses on developing "priming" therapies that help targeted treatments reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable to attack, and rendering healthy cells more receptive to treatment.